171 related articles for article (PubMed ID: 12615293)
1. Effects of statins on inflammation in patients with acute and chronic coronary syndromes.
Kinlay S; Selwyn AP
Am J Cardiol; 2003 Feb; 91(4A):9B-13B. PubMed ID: 12615293
[TBL] [Abstract][Full Text] [Related]
2. Statins and inflammation: an update.
Quist-Paulsen P
Curr Opin Cardiol; 2010 Jul; 25(4):399-405. PubMed ID: 20421792
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Wieland H
Herz; 2000 Mar; 25(2):117-25. PubMed ID: 10829251
[TBL] [Abstract][Full Text] [Related]
4. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
5. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
6. What the statin trials have taught us.
Waters DD
Am J Cardiol; 2006 Jul; 98(1):129-34. PubMed ID: 16784935
[TBL] [Abstract][Full Text] [Related]
7. Statins targeting inflammation by lowering low-density lipoprotein?
Tuzcu EM; Nicholls SJ
J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
[No Abstract] [Full Text] [Related]
8. A clinical focus on statins.
Auer J; Eber B
Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
[TBL] [Abstract][Full Text] [Related]
9. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
Rosenson RS
Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein levels and outcomes after statin therapy.
Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
[TBL] [Abstract][Full Text] [Related]
11. Using statins to treat inflammation in acute coronary syndromes: Are we there yet?
Shishehbor MH; Patel T; Bhatt DL
Cleve Clin J Med; 2006 Aug; 73(8):760-6. PubMed ID: 16913201
[TBL] [Abstract][Full Text] [Related]
12. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
Clearfield MB
J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein levels and outcomes after statin therapy.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):8-9. PubMed ID: 16455006
[No Abstract] [Full Text] [Related]
14. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
15. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
Vaughan CJ
Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
[TBL] [Abstract][Full Text] [Related]
16. Non-lipid-lowering effects of statins on atherosclerosis.
Rosenson RS
Curr Cardiol Rep; 1999 Sep; 1(3):225-32. PubMed ID: 10980846
[TBL] [Abstract][Full Text] [Related]
17. [Effects of statins on coronary artery disease. Review of the recent publications].
Bednarz B
Przegl Lek; 2003; 60(1):27-9. PubMed ID: 12884643
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of acute coronary syndromes and the potential role of statins.
Dupuis J
Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.
Kinlay S
J Am Coll Cardiol; 2007 May; 49(20):2003-9. PubMed ID: 17512355
[TBL] [Abstract][Full Text] [Related]
20. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
Koh KK
Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
